Drugs / Glycerol
Trials 8 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT04087421 Comparator | Sep 2019 → Dec 2026 expected | rectal cancer | University of Aarhus | Recruiting | No outcome recorded |
| Phase 3 | NCT00619203 Comparator | Mar 2008 → Mar 2012 | bacterial meningitis | Kamuzu University of Health Sciences | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01054989 Comparator | Mar 2009 → Sep 2011 | — | German Diabetes Center | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00786487 Comparator | Jan 2009 → Jan 2014 | — | University of Minnesota | Completed | No outcome recorded |
| — | NCT00152945 Background | Apr 2005 → Jul 2008 | — | University Health Network, Toronto | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glycerol | “Glycerol infusion over 6 hours” NCT01054989 ↗ |
| Known as | d5-glycerol | “the form of glycerol is d5-glycerol” NCT00152945 ↗ |
| Modality | Small molecule | “Leucine, an amino acid and glycerol, an intermediary metabolite” NCT00152945 ↗ |
| Route | Intravenous | “[2-13C]glycerol IV over 10 hours” NCT00005889 ↗ |